Jean-Christophe MONTIGNY

About Jean-Christophe MONTIGNY

Jean-Christophe MONTIGNY is the Chief Financial Officer of MEDIAN Technologies, a listed company focused on AI-powered medical imaging solutions. He joined the company in July 2021 and also serves on Median’s Executive Committee, reporting directly to Fredrik Brag, the company’s CEO and founder. His appointment was positioned as strategically important for the group’s next stock market and financial milestones, in a phase marked by growth, innovation, and international expansion. Before joining Median, Montigny built more than 25 years of senior management experience across subsidiaries of large groups and high-growth small and mid-sized companies financed by venture capital and public markets, particularly on Euronext Growth. His background is strongly anchored in corporate finance, growth acceleration, fundraising, and capital-market execution. He is especially associated with Biophytis SA, where he served as Chief Financial Officer and Deputy Chief Executive Officer from 2009 to 2019. At Biophytis, he was deeply involved in the company’s international development and played a key role in its listing on Euronext Growth. He also led the preparation phase for a potential NASDAQ listing, demonstrating experience in cross-border capital-market processes, financial structuring, and investor-facing strategy. This combination of operational finance and strategic market preparation is one of the defining features of his profile. At MEDIAN Technologies, these capabilities are highly relevant to financing the business, ensuring liquidity visibility, supporting investor relations, and helping execute the company’s broader roadmap in AI-enabled healthcare imaging. Recent company disclosures highlight his role in Median’s successful 2023 refinancing and in sustaining the company’s funding runway through the second quarter of 2025. That puts him at the center of the financial steering of a medtech company advancing both AI-based diagnostic products and imaging services for oncology clinical trials. Montigny holds an engineering degree from AgroParisTech and graduated from Sciences Po Paris. His profile combines technical training, strategic thinking, and deep capital-markets expertise, making him a significant executive figure in France’s listed healthcare and medtech ecosystem.